
Colgate-Palmolive ownership: holders and insider trading
$99.67+1.81%Close 13 Nov 2026 · Market value $80.21B
As filed, its directors and officers own 0.4% of the shares (proxy statement, 9 Mar 2026); 2,013 institutional managers reported holding 85.6% at 30 Jun 2026. Over the last twelve months, insiders sold $64.22M of shares on the open market, and bought none.
From the company's proxy statement, each holder's latest Schedule 13D or 13G, the institutional managers' quarterly 13F reports and the insiders' Form 4 filings. A percentage is shown as filed; one marked * is worked out here from the shares outstanding.
Largest holders
| Holder | Type | Shares | Of the company | Source | As of |
|---|
| The Vanguard Group | Holder | 84.9M | 10.68%* | Form 13F | 30 Jun 2026 |
|---|
| BlackRock, Inc. | Holder | 69.9M | 8.80%* | Form 13F | 30 Jun 2026 |
|---|
| Vanguard Capital Management | Holder | 60.4M | 7.52% | Schedule 13G | 31 Mar 2026 |
|---|
| State Street Corporation | Holder | 47.0M | 5.92%* | Form 13F | 30 Jun 2026 |
|---|
| T. Rowe Price | Institution | 27.9M | 3.51%* | Form 13F | 30 Jun 2026 |
|---|
| Geode Capital Management | Institution | 23.1M | 2.91%* | Form 13F | 30 Jun 2026 |
|---|
| Morgan Stanley | Institution | 22.1M | 2.78%* | Form 13F | 30 Jun 2026 |
|---|
| First Eagle Investment Management, LLC | Institution | 16.4M | 2.06%* | Form 13F | 30 Jun 2026 |
|---|
| BNY | Institution | 13.5M | 1.70%* | Form 13F | 30 Jun 2026 |
|---|
| Deutsche Bank | Institution | 11.8M | 1.48%* | Form 13F | 30 Jun 2026 |
|---|
| UBS | Institution | 10.6M | 1.33%* | Form 13F | 30 Jun 2026 |
|---|
| Norges Bank | Institution | 9.7M | 1.22%* | Form 13F | 30 Jun 2026 |
|---|
| Acadian Asset Management LLC | Institution | 9.1M | 1.14%* | Form 13F | 30 Jun 2026 |
|---|
| Fidelity (FMR) | Institution | 9.0M | 1.13%* | Form 13F | 30 Jun 2026 |
|---|
| Goldman Sachs | Institution | 8.6M | 1.08%* | Form 13F | 30 Jun 2026 |
|---|
| Northern Trust | Institution | 8.5M | 1.07%* | Form 13F | 30 Jun 2026 |
|---|
| Invesco | Institution | 8.3M | 1.05%* | Form 13F | 30 Jun 2026 |
|---|
| State Farm Mutual Automobile Insurance Co | Institution | 6.7M | 0.85%* | Form 13F | 30 Jun 2026 |
|---|
| Amundi | Institution | 6.2M | 0.78%* | Form 13F | 30 Jun 2026 |
|---|
| Bank of America | Institution | 6.2M | 0.78%* | Form 13F | 30 Jun 2026 |
|---|
Insider transactions latest 25
| Insider | Date | Transaction | Shares | Price | Value |
|---|
| Malcolm Gregory · EVP and Controller | 10 Nov 2026 | Open-market sale | −4.1K | $97.97 | $401.7K |
|---|
| NORRINGTON LORRIE M · Director | 5 Nov 2026 | Option exercise | +4.2K | $71.56 | $298.4K |
|---|
| NORRINGTON LORRIE M · Director | 5 Nov 2026 | Open-market sale | −4.2K | $99.31 | $414.1K |
|---|
| Wallace Noel R. · Chairman, President & CEO · Director | 5 Nov 2026 | Open-market sale | −20.0K | $100.26 | $2.01M |
|---|
| Tsourapas Panagiotis · COO, CD, EMEA, APac, Skin | 4 Nov 2026 | Option exercise | +19.9K | $76.41 | $1.52M |
|---|
| Tsourapas Panagiotis · COO, CD, EMEA, APac, Skin | 4 Nov 2026 | Open-market sale | −19.9K | $98.74 | $1.97M |
|---|
| Hazlin John · Chief Growth Officer | 4 Nov 2026 | Option exercise | +23.4K | $77.04 | $1.80M |
|---|
| Hazlin John · Chief Growth Officer | 4 Nov 2026 | Open-market sale | −23.4K | $99.15 | $2.32M |
|---|
| NORRINGTON LORRIE M · Director | 1 Oct 2026 | Grant or award | +300 | $87.42 | $26.23K |
|---|
| Newman Brian · Director | 1 Oct 2026 | Grant or award | +214 | $87.42 | $18.71K |
|---|
| BILBREY JOHN P · Director | 1 Oct 2026 | Grant or award | +271 | $87.42 | $23.69K |
|---|
| Wallace Noel R. · Chairman, President & CEO · Director | 16 Sep 2026 | Grant or award | +29.6K | — | — |
|---|
| GRANT SHANE · COO, Americas | 16 Sep 2026 | Grant or award | +7.4K | — | — |
|---|
| Tsourapas Panagiotis · COO, CD, EMEA, APac, Skin | 16 Sep 2026 | Grant or award | +4.6K | — | — |
|---|
| SUTULA STANLEY J III · Chief Financial Officer | 16 Sep 2026 | Grant or award | +8.0K | — | — |
|---|
| Hazlin John · Chief Growth Officer | 16 Sep 2026 | Grant or award | +3.9K | — | — |
|---|
| Massey Sally · Chief People Officer | 16 Sep 2026 | Grant or award | +3.3K | — | — |
|---|
| Fishbone Betsy · CLO and Secretary | 16 Sep 2026 | Grant or award | +2.2K | — | — |
|---|
| Malcolm Gregory · EVP and Controller | 16 Sep 2026 | Grant or award | +1.1K | — | — |
|---|
| Wallace Noel R. · Chairman, President & CEO · Director | 13 Sep 2026 | Shares withheld for tax | −4.9K | $86.80 | $424.6K |
|---|
| Tsourapas Panagiotis · COO, CD, EMEA, APac, Skin | 13 Sep 2026 | Shares withheld for tax | −922 | $86.80 | $80.03K |
|---|
| SUTULA STANLEY J III · Chief Financial Officer | 13 Sep 2026 | Shares withheld for tax | −1.4K | $86.80 | $120.2K |
|---|
| Massey Sally · Chief People Officer | 13 Sep 2026 | Shares withheld for tax | −686 | $86.80 | $59.54K |
|---|
| Malcolm Gregory · EVP and Controller | 13 Sep 2026 | Shares withheld for tax | −225 | $86.80 | $19.53K |
|---|
| Hazlin John · Chief Growth Officer | 13 Sep 2026 | Shares withheld for tax | −499 | $86.80 | $43.31K |
|---|
Form 4 filings since 16 Nov 2024: purchases and sales, grants, option exercises and shares withheld for tax. Gifts and other transfers are left out.
CL in the terminal
Holders over eight quarters by family, every Form 4 and Form 144 back two years, and alerts on insider buying.